Conexa Saúde

The founders' backgrounds are rooted in both business and medicine. Fernando Domingues, an economics graduate from Ibmec, had prior entrepreneurial experience before co-founding Conexa. Dr. Guilherme Weigert is a cardiologist who also founded Jaleko, a medical education platform, and brings a deep understanding of the healthcare sector's needs. Their combined expertise has guided the company's strategy to address inefficiencies and improve access within Brazil's healthcare system, where a large portion of the population relies on the public system.

Conexa's business model is primarily B2B and B2B2C, serving corporate clients, who offer the service as an employee benefit, and health insurance operators. It generates revenue by licensing its white-label software platform to hospitals and institutions and through its comprehensive network of healthcare professionals available 24/7. The platform facilitates on-demand virtual consultations across more than 30 medical specialties, patient monitoring, integrated electronic medical records, and digital prescriptions. The company emphasizes a preventive healthcare model, utilizing data analytics and predictive tools to deliver timely care and reduce costs.

Significant milestones include multiple funding rounds, such as a Series B in June 2020 and a Series C in June 2022, led by major investors like General Atlantic, Goldman Sachs, and e.Bricks Ventures. Vivo Ventures, a subsidiary of Telefônica, has also invested, aiming to leverage its vast distribution channel to expand healthcare access. Conexa has pursued a growth strategy that includes acquisitions, such as purchasing iMedicina, a medical software and electronic records developer, and Zenklub, an online therapy platform, to create an integrated health ecosystem. These moves have consolidated Conexa as a significant player in the digital health landscape, managing millions of patients and supporting tens of thousands of healthcare professionals.